Abexinostat

艾贝司他

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameAbexinostat
Drug Alias Name阿贝司他Abexinostatum阿诺司他PCI-24781S-78454 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsMetastatic breast cancerSkin MelanomaSolid tumours +[33] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[9] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesCelera
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesPharmacyclics LlcNa Pharma LtdXynomic Pharmaceuticals Inc +[5] 
Inactive CompaniesN/A
Active IndicationsSkin MelanomaSolid tumoursUreteral Neoplasms +[18] 
Inactive IndicationsMetastatic breast cancerUterine NeoplasmsFallopian Tube Neoplasms +[15] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG